Score tuberous sclerosis complex (TSC) organ involvement across SEGA, angiomyolipomata, pulmonary LAM, epilepsy severity, and neurodevelopmental domains to guide everolimus/sirolimus (mTORC1 inhibitor) therapy.
Score tuberous sclerosis complex (TSC) organ involvement across SEGA, angiomyolipomata, pulmonary LAM, epilepsy severity, and neurodevelopmental domains to guide everolimus/sirolimus (mTORC1 inhibitor) therapy
Each component has a specific meaning:
Note: Interpret the tsc severity score result against the thresholds and context described above.
Enter the SEGA, angiomyolipomata, pulmonary LAM, epilepsy severity, neurodevelopmental domains for the scenario you are assessing. Score tuberous sclerosis complex (TSC) organ involvement across SEGA, angiomyolipomata, pulmonary LAM, epilepsy severity, and neurodevelopmental domains to guide everolimus/sirolimus (mTORC1 inhibitor) therapy. Use the tsc severity score result to inform your calculation.